GENEVA, July 31 -- WESTLAKE LABORATORY OF LIFE SCIENCES AND BIOMEDICINE filed a patent application (CN2026/074860) for “NOVEL CLEAVABLE PEPTIDE AND USE THEREOF”. With publication no. WO/2026/158641, h... Read More
GENEVA, July 31 -- SHOUYAO HOLDINGS (BEIJING) CO., LTD filed a patent application (CN2026/074873) for “NOVEL HETEROCYCLIC COMPOUND”. With publication no. WO/2026/158642, here are the other details rel... Read More
GENEVA, July 31 -- JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. filed a patent application (CN2026/074845) for “AROMATIC AMIDE COMPOUND HAVING TRICYCLIC SKELETON AND USE THEREOF”. With publication no. WO... Read More
GENEVA, July 31 -- JASON FURNITURE (HANGZHOU) CO., LTD. filed a patent application (CN2026/074847) for “MECHANICAL EXTENSION STRUCTURE, SEAT UNIT, SOFA, AND CONTROL METHOD FOR SOFA”. With publication ... Read More
GENEVA, July 31 -- LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD. filed a patent application (CN2026/074852) for “NITROGEN-CONTAINING HETEROCYCLIC COMPOUND DUAL-TARGET INHIBITOR AND USE THEREOF”. With pu... Read More
GENEVA, July 31 -- LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD. filed a patent application (CN2026/074831) for “NITROGEN-CONTAINING HETEROCYCLIC COMPOUND SMALL-MOLECULE INHIBITOR AND USE THEREOF”. With... Read More
GENEVA, July 31 -- PEKING UNION MEDICAL COLLEGE HOSPITAL, CHINESE ACADEMY OF MEDICAL SCIENCES filed a patent application (CN2026/074836) for “ANTI-HHLA2 ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF, P... Read More
GENEVA, July 31 -- CHANGCHUN GENESCIENCE PHARMACEUTICAL CO., LTD. filed a patent application (CN2026/074843) for “PRODRUG BASED ON ENZYME CATALYSIS AND CHEMICAL CONVERSION”. With publication no. WO/20... Read More
GENEVA, July 31 -- QINGDAO KINGAGROOT CHEMICAL COMPOUND CO., LTD. filed a patent application (CN2026/074823) for “QUINAZOLINONE COMPOUND, PREPARATION METHOD THEREFOR, HERBICIDAL COMPOSITION THEREOF, A... Read More
GENEVA, July 31 -- CSPC MEGALITH BIOPHARMACEUTICAL CO., LTD. filed a patent application (CN2026/074824) for “PHARMACEUTICAL COMPOSITION COMPRISING ANTIBODY-DRUG CONJUGATE TARGETING ROR1”. With publica... Read More